CNBX Pharmaceuticals Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q2 2024.
  • CNBX Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending May 31, 2024 was 0 USD/shares.
  • CNBX Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending May 31, 2024 was 1.25 USD/shares.
  • CNBX Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was -0.42 USD/shares, a 88.3% increase from 2022.
  • CNBX Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was -3.59 USD/shares, a 17850% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.25 $0 +$0.02 Mar 1, 2024 May 31, 2024 10-Q 2024-07-15
Q1 2024 $1.23 $0 +$1.32 +99.2% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-16
Q4 2023 $0 $0 +$0.33 +100% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-12
Q3 2023 $0 $1.26 +$3.78 Jun 1, 2023 Aug 31, 2023 10-K 2023-11-30
Q2 2023 -$4 $0 +$0.03 +60% Mar 1, 2023 May 31, 2023 10-Q 2024-07-15
Q1 2023 -$4 -$1 $0 -31.7% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-16
Q4 2022 -$4 $0 $0 -3200% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-12
Q3 2022 -$4 -$3 Jun 1, 2022 Aug 31, 2022 10-K 2023-11-30
Q2 2022 $0 +$1.12 +95.7% Mar 1, 2022 May 31, 2022 10-Q 2023-07-14
Q1 2022 -$1 -$1 -25250% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-14
Q4 2021 $0 Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-13
Q2 2021 -$1 Mar 1, 2021 May 31, 2021 10-Q 2022-07-14
Q1 2021 $0 Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.